Human Papillomavirus Vaccine in Patients With Palmoplantar Warts
The therapeutic response to the quadrivalent or nonavalent human papillomavirus (HPV) vaccine in patients with palmoplantar warts is evaluated.
Diagnosis & Disease Information
Effect of a National Human Papillomavirus Immunization Program on Cervical Cancer Incidence
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
Incidence of Vaccine-Related and Nonvaccine Human Papillomavirus Types Among Adolescent Girls, Young Women in New York City
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.
Quadrivalent HPV Vaccine Prevents High-Grade Squamous Intraepithelial Lesions Among HIV-Positive Men
Researchers examined the efficacy and safety of the quadrivalent human papillomavirus vaccine for young men who have sex with men and are living with HIV.
HPV Vaccination Associated With Reduced Risk of Invasive Cervical Cancer
Study authors assessed the relationship between quadrivalent HPV vaccination and risk of invasive cervical cancer and age of vaccination.
HPV Prevalence Higher in Adults With More Than 5 Lifetime Sexual Partners
Clinicians must consider patient sexual history in the decision-making process for adult HPV vaccination.
HPV Vaccine Toolkit Increases Vaccination Rates in Primary Care
The purpose of this project is to implement and evaluate the effectiveness of the 4 Pillars Practice Transformation Program to increase uptake of the HPV vaccine among pediatric patients.
Extending HPV Vaccination to Age 45 Provides Small Additional Benefit
Extending the current human papillomavirus (HPV) vaccination program to age 45 years is expected to produce small additional reductions in HPV-associated diseases with high additional costs.
Mailing HPV Kits to Underscreened Women Can Up Screening
Mailing human papillomavirus (HPV) kits to underscreened women is associated with increased screening uptake but does not significantly increase precancer detection or treatment.
Most HPV-Linked Cancers Due to Types Targeted by 9vHPV Vaccine
In 2012 to 2016, an estimated 92% of cancers attributable to HPV were due to HPV types targeted by the 9vHPV vaccine.
- Loading...
Loading...
Next post in News
Loading... 
Loading...